M&A Deal Summary

H2 Equity Partners B.V. Acquires Aquilant

On August 8, 2018, private equity firm H2 Equity Partners B.V. acquired medical products company Aquilant from UDG Healthcare for 27M USD

Acquisition Highlights
  • This is H2 Equity Partners B.V.’s 5th transaction in the Medical Products sector.
  • This is H2 Equity Partners B.V.’s 2nd largest (disclosed) transaction.
  • This is H2 Equity Partners B.V.’s 9th transaction in the United Kingdom.

M&A Deal Summary

Date 2018-08-08
Target Aquilant
Sector Medical Products
Buyer(s) H2 Equity Partners B.V.
Sellers(s) UDG Healthcare
Deal Type Divestiture
Deal Value 27M USD

Target

Aquilant

Hampshire, United Kingdom
website
Aquilant Ltd. is a provider of healthcare and scientific products and services, providing outsourced sales, marketing, distribution and engineering for the medical and scientific sectors. Aquilant Ltd. was founded in 1987 and is based in Hampshire, United Kingdom.

Search 191,543 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

H2 Equity Partners B.V.

Amsterdam, Netherlands

Investor Investor Investor

website


Category Private Equity Firm
Founded 1991
PE ASSETS 500M EUR
Size Middle-Market
Type Sector Agnostic
DESCRIPTION
H2 Equity Partners' Amsterdam headquarters.
H2 Equity Partners' Amsterdam headquarters.

H2 Equity Partners is an independent private equity group focused on mid-sized turnaround-and-growth investments in the Benelux, Germany, and the UK. H2 looks for businesses facing operational, financial and/or managerial challenges, or sectors 'poised for consolidation'. H2 is a generalist investor, with no specific areas of interest. However, in the past, the firm has targeted opportunities in paper/board, steel, healthcare, media/communications, building products, consumer products, and fashion. H2 can invest in the rang of €5 to €25 million per transaction. H2 Equity Partners was formed in 1991 and has offices in Amsterdam, Munich, and London.


DEAL STATS #
Overall 46 of 53
Sector (Medical Products) 5 of 5
Type (Divestiture) 4 of 4
Country (United Kingdom) 9 of 14
Year (2018) 4 of 5
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-08-01 Healthcare 21

Ballincollig, Ireland

Healthcare 21 works with medical device companies and helps them drive growth and achieve quicker, more efficient routes to market through existing and new channels. The company supplies world-class training for healthcare products and provides state-of-the-art distribution and logistics, and asset tracking with speed and accuracy so that partners are always fully aware of their product’s journey in the supply chain and can rest assured delivery is safe, transparent, and fully accountable. Healthcare 21 was formed in 2003 and is headquartered in Ballincollig, Ireland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-09 Oerlemans Foods Nederland

Venlo, Netherlands

Oerlemans Foods Nederland is a specialist in frozen fresh vegetables, potato products and fruit for professionals.

Sell -

Seller(S) 1

SELLER

UDG Healthcare

Dublin, Ireland

website


Category Company
Founded 1948
Sector Business Services
Employees9,000
Revenue 1.3B USD (2020)
DESCRIPTION

UDG Healthcare operates in two segments, Ashfield and Sharp. Ashfield is a global integrated healthcare services partner offering a breadth of services in advisory, marketing, communications, strategic engagement, and patient solutions. Sharp engages in contract packaging, clinical, manufacturing, and technology services. UDG Healthcare was founded in 1948 and is based in Dublin, the Republic of Ireland.


DEAL STATS #
Overall 7 of 8
Sector (Medical Products) 3 of 3
Type (Divestiture) 7 of 8
Country (United Kingdom) 5 of 5
Year (2018) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-07-03 SmartAnalyst

New York, New York, United States

SmartAnalyst, Inc. is a strategic consulting and analytics business focused on the pharmaceutical and biotech sector. SmartAnalyst provides strategic consulting services to pharmaceutical and biotech companies to support disease, asset, and portfolio level decisions. SmartAnalyst, Inc. was founded in 2001 and is headquartered in New York city.

Buy $24M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-21 Putnam Associates

Boston, Massachusetts, United States

Putnam Associates is a consultancy focused on product commercialisation strategy, exclusively for the life sciences industry. Putnam Associates serves global biopharmaceutical, diagnostics, and medical device clients, along with private equity and venture capital clients, providing world-class strategic advice based on sophisticated, robust analytics. Putnam Associates was founded in 1988 and is based in Boston, Massachusetts.

Buy $89M